Two state attorneys general are investigating the pharmaceutical company Eli Lilly and Co.'s insulin pricing, the company said Monday.
The attorneys general of Washington and New Mexico are looking into the price of the Indianapolis, Ind.-based company's insulin products as well as its relationship with pharmacy benefit managers. Eli Lilly said in a Securities and Exchange Commission filing Monday that it was cooperating with the investigations.
